Product Information
MIRTAZAPINE 30 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0887 per EA under NDC 00378353005. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
30 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378353005
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MIRTAZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA076122On Market Since
6/20/2003
Price Statistics
The NADAC for MIRTAZAPINE 30 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 37.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0887 per EA |
|---|---|
| All-time high | $0.2592 (Aug 13, 2014) |
| All-time low | $0.0716 (Nov 20, 2024) |
| 52-week high | $0.0916 |
| 52-week low | $0.0858 |
| Median price | $0.1107 |
| Average price | $0.1245 |
| Largest weekly change | +24.5% (Dec 23, 2015) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MIRTAZAPINE 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIRTAZAPINE 30 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0887 per EA (NDC 00378353005), effective Jun 24, 2026.
How has the price of MIRTAZAPINE 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIRTAZAPINE 30 MG TABLET has declined 37.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MIRTAZAPINE 30 MG TABLET?
Since Nov 28, 2013, the NADAC for MIRTAZAPINE 30 MG TABLET has ranged from a low of $0.0716 (Nov 20, 2024) to a high of $0.2592 (Aug 13, 2014), with a median of $0.1107 per EA.
Are there cheaper alternatives to MIRTAZAPINE 30 MG TABLET?
Yes. 11 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, MIRTAZAPINE 30 MG TABLET, is $0.0723 per EA — about 19% below MIRTAZAPINE 30 MG TABLET.
Who manufactures MIRTAZAPINE 30 MG TABLET?
MIRTAZAPINE 30 MG TABLET (NDC 00378353005) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification